Jiyao Holding Group

Jiyao Holding Group Co., Ltd., formerly known as Tonghua Shuanglong Chemical Industry Co., Ltd., is a China-based pharmaceutical enterprise that has undergone a strategic transformation from specialty chemicals to healthcare. Following the acquisition of Jilin Jinhe Pharmaceutical and Tonghua Maoxiang Pharmaceutical, the company significantly expanded its presence in the Traditional Chinese Medicine (TCM) and chemical drug sectors. Its product portfolio features a range of treatments for oncology, cardiovascular conditions, and infectious diseases, with a notable presence in the Chinese domestic market for specialized TCM preparations. While the company retains its historical manufacturing roots in high-purity silica, its core focus is now the research and manufacturing of innovative and generic pharmaceuticals. Jiyao is publicly listed on the Shenzhen Stock Exchange under the ticker 300108.